Detalhe da pesquisa
1.
Adoptive T cell therapy for ovarian cancer.
Gynecol Oncol
; 186: 77-84, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603955
2.
CD137+ tumor infiltrating lymphocytes predicts ovarian cancer survival.
Gynecol Oncol
; 184: 74-82, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290413
3.
CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies.
Mol Ther
; 28(2): 548-560, 2020 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31870622
4.
DFMO Improves Survival and Increases Immune Cell Infiltration in Association with MYC Downregulation in the Pancreatic Tumor Microenvironment.
Int J Mol Sci
; 22(24)2021 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34947972
5.
Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells.
Cell Commun Signal
; 18(1): 95, 2020 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32552827
6.
An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer.
Gynecol Oncol
; 156(1): 222-232, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31818495
7.
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response.
Molecules
; 25(24)2020 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352773
8.
Difluoromethylornithine Combined with a Polyamine Transport Inhibitor Is Effective against Gemcitabine Resistant Pancreatic Cancer.
Mol Pharm
; 15(2): 369-376, 2018 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29299930
9.
PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival.
Front Immunol
; 15: 1383281, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711506
10.
A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression.
Clin Cancer Res
; 30(8): 1567-1581, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882675
11.
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies.
J Immunother Cancer
; 11(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37399356
12.
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study.
Clin Cancer Res
; 29(8): 1515-1527, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441795
13.
Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer.
Res Sq
; 2023 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37841875
14.
Induction of pancreatitis in mice with susceptibility to pancreatic cancer.
Methods Cell Biol
; 168: 139-159, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35366980
15.
Humanized Patient-Derived Xenograft Models of Ovarian Cancer.
Methods Mol Biol
; 2424: 255-274, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34918300
16.
Cryopreserved PM21-Particle-Expanded Natural Killer Cells Maintain Cytotoxicity and Effector Functions In Vitro and In Vivo.
Front Immunol
; 13: 861681, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35464440
17.
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma.
Commun Biol
; 5(1): 1260, 2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396952
18.
Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment.
Cancers (Basel)
; 13(24)2021 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34945011
19.
PD-L1 blockade enhances anti-tumor efficacy of NK cells.
Oncoimmunology
; 7(11): e1509819, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30377572
20.
Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells.
Oncotarget
; 7(6): 7318-28, 2016 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26802025